期刊文献+

三嵌段聚合物在药物制剂中的应用研究进展 被引量:1

Research Progresses in Application of Triblock Polymers in Pharmaceutical Preparations
原文传递
导出
摘要 三嵌段聚合物系由2种或2种以上不同化合物通过聚合反应而合成的一种新型多功能两亲性载体材料,在水溶液中呈现优良的自组装性能。其用作药物载体时,可依据需求,通过改变其组成和结构而使其拥有温度敏感、pH敏感、磁敏感等多种特性,将其制成适宜剂型,能达到改善药物的溶解性等理化性质以及靶向性、缓控释性和生物利用度的目的,其在药物制剂领域具有广阔的应用前景。简介各种类型的三嵌段聚合物,着重概述近年来三嵌段聚合物在不同制剂剂型中的应用研究。 Triblock polymers are a kind of new multifhnctional amphiphilic carrier materials which are synthesized by using two or more different compounds by polymerization and offer an excellent self-assembling pertbrmance in aqueous solution. When used as drug carriers, they could exhibit a variety of properties such as temperature sensitivity, pH sensitivity and magnetic sensitivity by changing their components and structures and improve the physico-chemical properties(such as solubility), targeting, sustained, controlled release properties and bioavailability of drugs to prepare appropriate dosage lbrms according to requirement.So triblock polymers have a broad application prospect in the field of pharmaceutical preparations. The various types of triblock polymers have been introduced. Especially, the recent applications of triblock polymers in different dosage forms of pharmaceutical preparations have been summarized.
出处 《药学进展》 CAS 2014年第7期515-520,共6页 Progress in Pharmaceutical Sciences
关键词 三嵌段聚合物 自组装 载体 药物制剂 triblock polymer self-assembly carrier pharmaceutical preparation
  • 相关文献

参考文献26

  • 1魏川.功能性嵌段聚合物的合成、自组装及初步应用[D].上海:复旦大学,2011.
  • 2Alfonso F. New drug-eluting stents: polymer-free, biodegradable polymers or bioabsorbable scaftblds?[J]. Rev Esp Cardiol, 2013, 66(6): 423-426.
  • 3Wijting W K, van Reenen A, Laven J, et al. Competitive adsorption of (phosphorylated) ethoxylated styrene oxide polymer and polyacrylic acid on silica coated iron oxide pigment[J]. Colloids Surf A Physicochem [J].Asp, 2014, 449: 19-30.
  • 4朱琴琴.多嵌段聚合物制各的新方法研究[D].杭州:浙江大学,2012.
  • 5Krol P, Chmielarz P. Recent advances in ATRP methods in relation to the synthesis of copolymer coating materials[J]. Prog Org Coat, 2014, 77(5): 913-948.
  • 6Visnevskij C, Ciuta G, Ketleriute S, et al. ISARA ATRP of methacrylic acid neutralized by simple amines yielding linear polymers and anionic molecular brushes[J]. Eur Polym J, 2014.55: 66-75.
  • 7Park K C, ldota N. Tsukahara T. Synthesis of NIPAAm-based polymergrafted silica beads by surface-initiated ATRP using Me4Cyclam ligands and the thermo-responsive behaviors for lanthanide(III) ions[J]. React Funct Polym, 2014, 79: 36-46.
  • 8Ran J, Wu L, Zhang Z, et al. Atom transfer radical polymerization (ATRP): a versatile and forceful tool for functional membranes[J]. Prog Polym SCi, 2014, 39(1): 124-144.
  • 9Cavallaro G, Licciardi M, Amato G, et al. Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery[J].lnt J Pharm, 2014, 466(1/2): 246-257.
  • 10Wang J, Leung L M. Self-assembly and aggregation of ATRP prepared amphiphilic BAB tri-block copolymers contained nonionic ethylene glycol and tluorescent 9, 10-di(l-naphthalenyl)-2-vinyl-anthracenellvinyl-pyrene segments[J]. Eur PolymJ, 2013, 49(11): 3722-3733.

二级参考文献25

  • 1郭欢迎,刘海静,李秀珍.阿咖片中阿司匹林溶出测定研究[J].西北药学杂志,2000,15(z1):32-33. 被引量:1
  • 2Yongrui LI,Nanlin SHI.Synthesis of Ultrafine Fe_3O_4 Powder via a Novel Ageing Process[J].Journal of Materials Science & Technology,2005,21(4):606-608. 被引量:2
  • 3Bergmann T K,Green H,Brasch-Andersen C,et al. Retrospective study of the impact ofpharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer[J]. EuropeanJournal of Clinical Pharmacology , 2011,67(1) : 693-700.
  • 4Chopra A,Kim T S I O S,Martinez D,et al. Combined therapy of an established,highly aggressivebreast cancer in mice with paclitaxel and a unique DNA-based cell vaccine [J]. Int J Cancer, 2006,118(11): 2888-2898.
  • 5Stathopoulos G P, Katis C,Tsavdaridis D,et al. Front-line paclitaxel and topotecan chemotherapy inadvanced or metastatic non-small-cell lung cancer: a phase II trial [J]. Cancer Chemotherapy andPharmacology , 2006,58(11) : 555-560.
  • 6Iesalnieks I,Tange S,Scherer M N, et al. Paclitaxel promotes liver graft survival in rats and inhibitshepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with livercancer[J]. TVansf/a.^ _Proc,2002,34(6) : 2316-2317.
  • 7Spencer C M,Faulds D. Paclitaxel-a review of its pharmacodynamic and pharmacokinetic properties andtherapeutic potential in the treatment of cancer[J]. Drug,1994,48(5) : 794-847.
  • 8Liggins R T,Burt H M. Polyether-polyester diblock copolymers for the preparation of paclitaxel loadedpolymeric micelle formulations [J], Advanced Drug Delivery Reviews,2002,54(2) : 191-202.
  • 9Zhang X C,Jackson J K,Burt H M. Development of amphiphilic diblock copolymers as micellar carriers oftaxolOriginal Research Article [J]. Int J Pharm . 1996,132(1-2) : 195-206.
  • 10Dong Y C, Feng S S. Methoxy poly ( ethylene glycol )-poly ( lactide) (MPEG-PLA) nanoparticles forcontrolled delivery of anticancer drugs [J], Biomaterials^ 2004,25(14) : 2843-206.

共引文献8

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部